Fungal Diseases Caused by Serious Contamination of Pharmaceuticals and Medical Devices, and Rapid Fungal Detection Using Nano-Diagnostic Tools: A Critical Review
- PMID: 37978091
- PMCID: PMC10656328
- DOI: 10.1007/s00284-023-03506-7
Fungal Diseases Caused by Serious Contamination of Pharmaceuticals and Medical Devices, and Rapid Fungal Detection Using Nano-Diagnostic Tools: A Critical Review
Abstract
Fungal-contaminated compounded pharmaceuticals and medical devices pose a public health problem. This review aimed to provide an organized overview of the literature on that critical issue. Firstly, it was found that compounding pharmacies can produce drugs that are contaminated with fungi, leading to outbreaks of severe fungal diseases. Secondly, inadequate sterile compounding techniques or storage conditions, or exceeding the limit of a fungal count, can result in fungal contamination. Lastly, nanotools can be used to rapidly detect fungi, thus improving fungal diagnostic procedures. To achieve this goal, we have reviewed the published data on PubMed, the CDC, and FDA Web sites, and a literature search was undertaken to identify severe fungal infections associated with compounding pharmacies outside of hospitals, limited by the dates 2003 to 2021. The "Preferred Reporting Items for Critical Reviews" were followed in searching, including, and excluding papers. Fungal outbreaks have been documented due to contaminated pharmaceuticals and medical devices. In 2013, 55 people died from fungal meningitis caused by contaminated steroid injections containing methylprednisolone acetate. Additionally, in 2021, Aspergillus penicillioides contamination was reported in ChloraPrep drugs, which was attributed to the storage conditions that were conducive to the growth of this fungus. These incidents have resulted in severe infectious diseases, such as invasive mycoses, cornea infections, Endophthalmitis, and intestinal and gastric mycosis. By implementing preventive measures and policies, it is possible to avoid these outbreaks. Creating Nano-diagnostics presents a major challenge, where promptly diagnosing fungal infections is required to determine the proper corrective and preventive measures.
© 2023. The Author(s).
Conflict of interest statement
All authors have no conflict of interest.
Figures




Similar articles
-
Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.Am J Health Syst Pharm. 2013 Aug 1;70(15):1301-12. doi: 10.2146/ajhp130049. Am J Health Syst Pharm. 2013. PMID: 23867487 Free PMC article. Review.
-
Sterile compounding: clinical, legal, and regulatory implications for patient safety.J Manag Care Spec Pharm. 2014 Dec;20(12):1183-91. doi: 10.18553/jmcp.2014.20.12.1183. J Manag Care Spec Pharm. 2014. PMID: 25443512 Free PMC article. Review.
-
Update on Multistate Outbreak of Fungal Infections Associated with Contaminated Methylprednisolone Injections, 2012-2014.MMWR Morb Mortal Wkly Rep. 2015 Oct 30;64(42):1200-1. doi: 10.15585/mmwr.mm6442a4. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26513534
-
Fungal infections associated with contaminated methylprednisolone injections.N Engl J Med. 2013 Oct 24;369(17):1598-609. doi: 10.1056/NEJMoa1213978. Epub 2012 Dec 19. N Engl J Med. 2013. PMID: 23252499
-
Fungal infections associated with contaminated methylprednisolone in Tennessee.N Engl J Med. 2012 Dec 6;367(23):2194-203. doi: 10.1056/NEJMoa1212972. Epub 2012 Nov 6. N Engl J Med. 2012. PMID: 23131029 Free PMC article.
Cited by
-
Microbiological Contamination of Medicinal Products -Is It a Significant Problem?Pharmaceuticals (Basel). 2025 Jun 23;18(7):946. doi: 10.3390/ph18070946. Pharmaceuticals (Basel). 2025. PMID: 40732236 Free PMC article. Review.
-
Unraveling the Nano World in Paracoccidioidomycosis: Promising Applications of Nanotechnology in Diagnosis, Treatment, and Vaccines: A Mini Review.Curr Microbiol. 2025 Apr 28;82(6):264. doi: 10.1007/s00284-025-04251-9. Curr Microbiol. 2025. PMID: 40295332 Review.
-
Detection and characterization of micro-organisms linked to unsealed drugs sold in Ihiagwa community, Owerri, Imo State, Nigeria.Access Microbiol. 2024 Feb 16;6(2):000752.v3. doi: 10.1099/acmi.0.000752.v3. eCollection 2024. Access Microbiol. 2024. PMID: 38482350 Free PMC article.
References
-
- FDA , 2015, Compounding and the FDA: Questions and answers. Available at: http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm339764.htm
-
- Kastango EC, Douglass KH. Clinical IQ LLC. [Accessed Jan 5, 2015] Quality standards for large scale sterile compounding facilities. doi: 10.1093/ajhp/61.18.1928.
-
- United States Pharmacopia, Microbiological Tests. In: The United States Pharmacopeia, 30th revision and the National Formulary, 25th edition (USP-NF). Rockville, Maryland; United States Pharmacopeial Convention, 2007.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical